백신실용화기술개발사업단

한국보건산업진흥원에서 발간한 "바이오의약품 산업 분석 및 정책 연구"보고서 입니다.

<목 차>

제1장. 서 론 ························································································1

 1. 연구의 배경 및 목적 ········································································3

 2. 연구 내용 및 방법 ············································································5

제2장. 바이오의약품 개념 및 정의 ····················································9

 1. 의약품 정의 및 분류 ······································································11

 2. 바이오의약품 특성 및 유형 ···························································19

제3장. 글로벌 바이오의약품 산업 및 정책 동향 ·····························31

 1. 글로벌 바이오의약품 산업 동향 ···················································33

 2. 글로벌 바이오의약품 연구개발 동향 ············································68

 3. 글로벌 바이오의약품 정책 동향 ·················································109

 4. 소결 ································································································128

제4장. 국내 바이오의약품 산업 및 정책 동향 ······························131

 1. 국내 바이오의약품 산업 현황 ·····················································133

 2. 국내 바이오의약품 연구개발 동향 ·············································150

 3. 국내 바이오의약품 산업 정책 동향 ···········································193

 4. 소결 ································································································206

제5장. 국내 바이오의약품 산업 경쟁력 분석 ································211

 1. 조사 개요 ·······················································································213

 2. 조사 결과 ·······················································································214

제6장. 결론 및 정책 제언 ······························································225

 1. 연구 결과 ·······················································································227

 2. 정책 제언 ·······················································································230

   ▪ 참고문헌 ·····················································································243

   ▪ 부 록 ·····················································································251

【부록】 전문가 델파이 조사표 ··························································253

출처: 한국보건산업진흥원